MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Cash from Financing Activities (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Cash from Financing Activities came in at $5.3 million in Q4 2025, up 25.54% YoY from $4.2 million in Q4 2024, and up 2532.88% on a QoQ basis from -$219000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Cash from Financing Activities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Cash from Financing Activities data on file, last reported at $5.3 million in Q4 2025.

  • Quarterly Cash from Financing Activities rose 25.54% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.3 million (down 77.5% YoY) and the FY2025 annual result came in at $12.3 million, down 77.5% from the prior year.
  • Cash from Financing Activities grew to $5.3 million in Q4 2025, from -$219000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $72.9 million in Q3 2022 to a low of -$2.6 million in Q1 2022.
  • A 5-year average of $13.0 million and a median of $1.6 million in 2024 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 134990.74% in 2022, down 1998.53% in 2022.
  • Tracing MGTX's Cash from Financing Activities over 5 years: stood at $1.3 million in 2021, then surged by 1817.61% to $24.8 million in 2022, then increased by 11.59% to $27.7 million in 2023, then slumped by 84.68% to $4.2 million in 2024, then gained by 25.54% to $5.3 million in 2025.
  • The last three Cash from Financing Activities figures came in at $5.3 million (Q4 2025), -$219000.0 (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 14.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.42 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -6.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 36.24 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -273.15 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 27.18 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.33 Mn
Sep 30, 2025 -219,000.00
Jun 30, 2025 5.45 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 4.24 Mn
Sep 30, 2024 49.96 Mn
Jun 30, 2024 1.60 Mn
Mar 31, 2024 -1.27 Mn
Dec 31, 2023 27.71 Mn
Sep 30, 2023 -404,000.00
Jun 30, 2023 57.95 Mn
Mar 31, 2023 -1.23 Mn
Dec 31, 2022 24.83 Mn
Sep 30, 2022 72.95 Mn
Mar 31, 2022 -2.58 Mn
Dec 31, 2021 1.30 Mn
Sep 30, 2021 54,000.00
Jun 30, 2021 223,000.00
Mar 31, 2021 136,000.00
Dec 31, 2020 69.44 Mn